bioAffinity Technologies Inc (BIAF) Price Prediction & ForecastBIAFbioAffinity Technologies Inc

Alphio's BIAF stock price prediction model matches the current bioAffinity Technologies Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.79 (+0.54%). The 1-week path is $2.85 (+2.66%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Currently, bioAffinity Technologies Inc (BIAF) is not a strong buy due to its significant financial challenges. The stock is trading at $2.78, which is 96.55% below its 52-week high of $80.70, indicating severe underperformance. Additionally, the company reported a staggering 84.81% year-to-date decline, and its recent revenue dropped by 27% to $1.4 million in Q1 2026. While there are some positive signs, such as a recent partnership with AvMEDICAL, the ongoing losses and negative cash flow are concerning. The main risk is the net income, which has been consistently negative, with a reported loss of $3.36 million in Q2 2026.

bioAffinity Technologies Inc (BIAF) last closed at $2.7799001, gaining +6.92%. These facts feed the 1-day and 1-week BIAF price prediction above.